Nobel Prize Winner Faces Investigation into Paper Integrity

Seventeen studies coauthored by Gregg Semenza have been retracted, corrected, or raised for concern, and 15 more are currently under investigation.

Written byKatherine Irving
| 2 min read
a black pencil with a white eraser on the tip leaves eraser marks on a piece of paper
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Nobel laureate and renowned physician and scientist Gregg Semenza is facing more than 15 additional paper investigations from various publications, an investigation conducted by Nature has found. Semenza has already seen 17 of his papers retracted, corrected, or raised for concern since 2011. Four were retracted from PNAS just last month. Of the 17 papers of concern, five were retracted as a result of image manipulation, Nature reports.

Semenza shared the 2019 Nobel Prize in Physiology or Medicine with two other scientists for his work on cellular oxygen regulation, and shared the Lasker Award for basic medical research in 2016 for the same work. However, even before he received these awards, some scientists were suspicious of his published results. Users on the website PubPeer, which allows commenters to flag apparent errors or fabrications in published research, have found potential problems in 54 publications on which Semenza is an author.

“I ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot of Katherine Irving

    Katherine Irving is an intern at The Scientist. She studied creative writing, biology, and geology at Macalester College, where she honed her skills in journalism and podcast production and conducted research on dinosaur bones in Montana. Her work has previously been featured in Science.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies